Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
Expedited Access to Biosimilars Act is an essential step forward that modernizes the biosimilar approval pathway. We applaud